Abstract:Thioredoxin-interacting protein (TXNIP) plays a critical role in glucose metabolism and redox signaling. TXNIP has recently emerged as a potent tumor suppressor in various cancer models. In previous studies, we found TXNIP was activated by UNC0642, an inhibitor of histone methyltransferase, in MDA-MB-231 breast cancer cells. TXNIP activation was coupled with significant suppression of cell proliferation and tumor growth. In contrast, TXNIP knockdown increased MDA-MB-231 cell proliferation and in tumor growth and metastasis in vivo. TXNIP-reconstitution in TXNIP-deficient HCC1954 cells reduced cell proliferation and migration coupled with increased reactive oxygen species production. TXNIP-reconstitution also significantly decreased mitochondrial respiration, mitochondrial membrane potential and glycolysis in HCC1954 cells. To understand the mechanisms underlying TXNIP's antitumor activity, we performed co-immunoprecipitation and proteomic analyses to uncover TXNIP-interacting proteins. We identified calpastatin (CAST) as a novel TXNIP-interacting protein in breast cancer cells. CAST is an endogenous inhibitor of calpains, a family of calcium-activated cysteine proteases. Intriguingly, CAST association with TXNIP was readily detectable in TXNIP-low, but not in TXNIP-high breast cancer cells. The disassociation of CAST from TXNIP in TXNIP-high cells might allow CAST to inhibit calpain activity to augment TXNIP's antitumor function. Through RNAseq analysis, we identified a positive correlation between TXNIP expression and IL-24 activation in various breast cancer cells, which were also confirmed by western blotting. IL-24 has emerged as an important cancer therapy target because of its role in promoting cancer-specific apoptosis. Our data also demonstrated that TXNIP upregulated the level of IL-24 and downregulated STAT-3. Moreover, TXNIP exerts multifaceted effects on BC development through the IL24-STAT3 signaling axis, deepening our understanding of its complex role in the disease. Taken together, these studies identified novel TNXIP-dependent pathways and their potential new mechanisms in breast cancer pathogenesis with significant clinical implications. Citation Format: Jasvinder Singh, Bindeshwar Sah, Robert Clarke, Liang Liu. Identification of novel TXNIP-dependent antitumor pathways in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4378.

TXNIP Gene in Tumorigenesis and Metastasis

Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers

The Role of TXNIP in Cancer: a Fine Balance Between Redox, Metabolic, and Immunological Tumor Control

TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook

Abstract P2-16-02: TXNIP-dependent tumor suppressive pathways in breast cancer growth and progression

TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target

Redox-Dependent And Independent Effects Of Thioredoxin Interacting Protein

Hypoxia induced high expression of thioredoxin interacting protein (TXNIP) in non-small cell lung cancer and its prognostic effect.

Identification of Thioredoxin-1 As a Biomarker of Lung Cancer and Evaluation of Its Prognostic Value Based on Bioinformatics Analysis

Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein

Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer

Tissue Thioredoxin-Interacting Protein Expression Predicted Recurrence in Patients with Meningiomas

Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway

Decreased expression of TXNIP is associated with poor prognosis and immune infiltration in kidney renal clear cell carcinoma

Silencing thioredoxin induces liver cancer cell senescence under hypoxia.

TXNIP-mediated crosstalk between oxidative stress and glucose metabolism

The role of TXNL1 in disease: treatment strategies for cancer and diseases with oxidative stress

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker

A Novel Indication of Thioredoxin-Interacting Protein As A Tumor Suppressor Gene in Malignant Glioma

Abstract 4378: Identification of novel TXNIP-dependent antitumor pathways in breast cancer

The role and mechanism of thioredoxin-interacting protein in ischemia-reperfusion injury